Pramlintide but Not Liraglutide Suppresses Meal-Stimulated Glucagon Responses in Type 1 Diabetes

Moving beyond subcutaneous insulin: the application of adjunctive therapies to the treatment of type 1 diabetes

(2017) Kathleen H. Ang et al.   Expert Opinion on Drug Delivery

Efficacy and Safety of Liraglutide Added to Capped Insulin Treatment in Subjects With Type 1 Diabetes: The ADJUNCT TWO Randomized Trial

(2016) Bo Ahrén et al.   DIABETES CARE

Addition of Liraglutide to Insulin in Patients With Type 1 Diabetes: A Randomized Placebo-Controlled Clinical Trial of 12 Weeks

(2016) Nitesh D. Kuhadiya et al.   DIABETES CARE

Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial

(2016) Chantal Mathieu et al.   DIABETES CARE

Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and Liraglutide

(2016) Jennifer L. Sherr et al.   DIABETES CARE

Gastrointestinal actions of glucagon-like peptide-1-based therapies: glycaemic control beyond the pancreas

(2016) M. M. Smits et al.   DIABETES OBESITY & METABOLISM

THE EMERGING ROLE OF ADJUNCTIVE NONINSULIN ANTIHYPERGLYCEMIC THERAPY IN THE MANAGEMENT OF TYPE 1 DIABETES

(2016) Bruce W. Bode et al.   Endocrine Practice

Effect of Pramlintide on Postprandial Glucose Fluxes in Type 1 Diabetes

(2016) Ling Hinshaw et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Combination therapy with liraglutide and insulin in Japanese patients with type 2 diabetes: A 36-week, randomized, double-blind, parallel-group trial

(2016) Yutaka Seino et al.   Journal of Diabetes Investigation

Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial

(2016) Thomas Fremming Dejgaard et al.   Lancet Diabetes & Endocrinology

Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus

(2016) Christian Seerup Frandsen et al.   Lancet Diabetes & Endocrinology

Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis

(2016) Jason H Y Wu et al.   Lancet Diabetes & Endocrinology

Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label Trial

(2015) Juris J. Meier et al.   DIABETES CARE

Evolution of Abnormal Plasma Glucagon Responses to Mixed-Meal Feedings in Youth With Type 1 Diabetes During the First 2 Years After Diagnosis: Figure 1

(2014) Jennifer Sherr et al.   DIABETES CARE

Liraglutide and the Preservation of Pancreatic β-Cell Function in Early Type 2 Diabetes: The LIBRA Trial

(2014) Ravi Retnakaran et al.   DIABETES CARE

The influence of glucagon on postprandial hyperglycaemia in children 5 years after onset of type 1 diabetes

(2014) Siri Fredheim et al.   DIABETOLOGIA

Liraglutide as Additional Treatment to Insulin in Obese Patients with Type 1 Diabetes Mellitus

(2013) Nitesh Kuhadiya et al.   Endocrine Practice

Effect of Pramlintide on Prandial Glycemic Excursions During Closed-Loop Control in Adolescents and Young Adults With Type 1 Diabetes

(2012) S. A. Weinzimer et al.   DIABETES CARE

Liraglutide: short-lived effect on gastric emptying-long lasting effects on body weight

(2012) J. Jelsing et al.   DIABETES OBESITY & METABOLISM

Pramlintide Lowered Glucose Excursions and Was Well-Tolerated in Adolescents with Type 1 Diabetes: Results from a Randomized, Single-Blind, Placebo-Controlled, Crossover Study

(2009) H. Peter Chase et al.   JOURNAL OF PEDIATRICS

Too Much Glucagon, Too Little Insulin: Time course of pancreatic islet dysfunction in new-onset type 1 diabetes

(2008) R. J. Brown et al.   DIABETES CARE

Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial Pancreas

(2008) S. A. Weinzimer et al.   DIABETES CARE